First floor-south wing
etc.venues St Paul's
200 Aldersgate
London
EC1A 4HD
United Kingdom
The annual ELIXIR Bioinformatics Industry Forum is a one-day event that brings together bioinformaticians and technical specialists to explore solutions to major challenges in the data-driven life science sector.
This year’s Forum theme is "Trusted research environments for sensitive data in the life sciences". The programme features a variety of presentations from industry and academia, offering the participants a chance to learn more about relevant initiatives and research breakthroughs in the area of TREs. The forum aims to stimulate discussions among solution providers and enable potential collaborations.
08:30 |
Registrations and welcome coffee First floor-south wing |
09:30 - 9:40 |
Welcome to the event by ELIXIR (Despoina Sousoni) & EMBL-EBI (Matthew Hall) |
9:40- 11:00 |
Session 1: How partnerships can help us tackle big challenges and seize big opportunities in Trusted Research Environments for sensitive and restricted data The session will feature presentations from different initiatives and organisations that are working on developing and using Trusted Research Environments, and share their experiences in building collaborative efforts to achieve big goals and challenging tasks in this domain. Part one: ELIXIR Introduction by Harald Wagener, Juan Arenas, Peter Maccallum 10min presentations, 10min common Q&A Part two Speakers: 10min presentations, 10min common Q&A
|
11:00 - 11:30 |
Coffee break |
11:30 - 13:00 |
Session 2: Technical solutions for enabling data access and analysis in Trusted Research Environments for life sciences The presentations will showcase the benefits of the service and identify the current gaps/challenges for advancing the application. This aims to trigger discussions among solution providers and foster potential collaborations. 10min each presentation, 10min common Q&A Part one
Part two
|
13:00 - 14:00 |
Lunch break |
14:00 - 14:45 |
Panel discussion on Interoperability, privacy, and sustainability in Trusted Research Environments for life sciences: challenges and opportunities for innovation The panel discussion will explore how to address the issues of interoperability and reusability of solutions, privacy and ethics, commercial use of data, management and governance challenges, and rewarding systems in Trusted Research Environments for life sciences. Panellists:
|
14:40 - 16:55 |
Round-table discussions 3-min Flash talk introductory presentations of the topics Two rounds of 40 min discussions
3min wrap up presentations of the discussions |
16:55-17:00 | Wrap-up session |
1h Networking drinks |
Theme and objectives of the event
Theme summary: Data-centric research relies on accessing and combining large-scale, sensitive data sets for analysis. These data sets require Trusted Research Environments (TREs) that offer data access and analysis with robust data management, governance and technology. However, the current landscape of TREs for sensitive or restricted data is very fragmented and lacks a common reference architecture for connectivity and interoperability.
To overcome this fragmentation and promote collaboration among different stakeholders, we need a framework for large-scale partnerships on sensitive and restricted data through a network of TREs. ELIXIR is hosting a Bioinformatics Industry Forum on this topic with the aim of fostering a collaborative approach to address these challenges.
Objectives
- Learn from best practices and experiences of established players
- Understand the relevant ecosystem
- Discover existing gaps and potential research business opportunities
- Gain insights into research and technological breakthroughs
- Encourage discussions among solution providers and foster potential collaborations
Target audience
Professionals from:
- Large, medium and small enterprises
- Funding bodies
- Academia
- Nonprofit and public organisations
- Patients’ and clinicians’ associations
With research interests in:
- Health and life sciences
- Data management
- Innovative services in the above areas
Programme Committee

- Joanne Hackett, Vice President Genomic & Precision Medicine, IQVIA


- Peter Maccallum, Chief Technical Officer, ELIXIR Hub


- Serena Scollen, Head of Human Genomics and Translational Data, ELIXIR Hub


- Salvador Capella, Team Lead, Barcelona Supercomputing Center
Travel information
Address: First floor-south wing, 200 Aldersgate, London EC1A 4HD
By underground
St. Paul's - Central line
On exiting the station follow St Martin Le-Grand north towards Aldersgate Street and the Museum of London. When you arrive at the Museum of London roundabout our venue is located on the left. Look for the circular artwork in the window and go through the revolving doors.
Barbican - Circle, Metropolitan and Hammersmith & City lines
On exiting the station turn right on to Aldersgate Street. Follow Aldersgate Street south towards London Wall and the Museum of London. As you arrive at the roundabout for Museum of London our venue is on the right. Cross over the zebra crossing and look for the circular artwork in the window and go through the revolving doors to reception.
By train
Aldersgate Station is located near Moorgate and Farringdon railway stations, and is around a 10 minute walk from both.
By bus
The closest bus stop is at the Museum of London and is served directly by the number 4 and 56. Other services also serve Barbican and St. Paul's and our venue is a short walk from both these locations.
Parking
The closest car park is located next to the venue at 158 – 170 Aldersgate Street. Visit www.ncp.co.uk for more details.
See also the venue travel information.
Accommodation
Participants and speakers are expected to make their own accommodation arrangements. The recommended hotel is Premier Inn London Blackfriars, which is located 13 min walking distance from the venue.
Background information
See the Bioinformatics Industry Forum page.
participants per event, on average
companies joined our two F2F events
of participants would recommend the event to their colleagues
- Sebastian Schwarz (Data Platform Strategy Lead, Owkin)
- Anonymous
- Anonymous